141 related articles for article (PubMed ID: 24747293)
1. A robotic BG1Luc reporter assay to detect estrogen receptor agonists.
Stoner MA; Yang CZ; Bittner GD
Toxicol In Vitro; 2014 Aug; 28(5):916-25. PubMed ID: 24747293
[TBL] [Abstract][Full Text] [Related]
2. A robotic MCF-7:WS8 cell proliferation assay to detect agonist and antagonist estrogenic activity.
Yang CZ; Casey W; Stoner MA; Kollessery GJ; Wong AW; Bittner GD
Toxicol Sci; 2014 Feb; 137(2):335-49. PubMed ID: 24213142
[TBL] [Abstract][Full Text] [Related]
3. Chemicals having estrogenic activity can be released from some bisphenol A-free, hard and clear, thermoplastic resins.
Bittner GD; Denison MS; Yang CZ; Stoner MA; He G
Environ Health; 2014 Dec; 13():103. PubMed ID: 25477047
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
Wilson VS; Bobseine K; Gray LE
Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
[TBL] [Abstract][Full Text] [Related]
5. Estrogenic chemicals often leach from BPA-free plastic products that are replacements for BPA-containing polycarbonate products.
Bittner GD; Yang CZ; Stoner MA
Environ Health; 2014 May; 13(1):41. PubMed ID: 24886603
[TBL] [Abstract][Full Text] [Related]
6. Performance of the BG1Luc ER TA method in a qHTS format.
Ceger P; Allen D; Huang R; Xia M; Casey W
ALTEX; 2015; 32(4):287-96. PubMed ID: 26117232
[TBL] [Abstract][Full Text] [Related]
7. Development of a recombinant human ovarian (BG1) cell line containing estrogen receptor α and β for improved detection of estrogenic/antiestrogenic chemicals.
Brennan JC; Bassal A; He G; Denison MS
Environ Toxicol Chem; 2016 Jan; 35(1):91-100. PubMed ID: 26139245
[TBL] [Abstract][Full Text] [Related]
8. In vitro OECD test methods applied to screen the estrogenic effect of chemicals, used in Korea.
Lee HS; Park EJ; Han S; Oh GY; Kim MH; Kang HS; Suh JH; Oh JH; Lee KS; Hwang MS; Moon G; Hong JH; Hwang IG
Food Chem Toxicol; 2016 Sep; 95():121-7. PubMed ID: 27317829
[TBL] [Abstract][Full Text] [Related]
9. Integral assessment of estrogenic potentials of sediment-associated samples. Part 1: The influence of salinity on the in vitro tests ELRA, E-Screen and YES.
Kase R; Hansen PD; Fischer B; Manz W; Heininger P; Reifferscheid G
Environ Sci Pollut Res Int; 2008 Jan; 15(1):75-83. PubMed ID: 18306891
[TBL] [Abstract][Full Text] [Related]
10. Estrogenic effects of herbal medicines from Costa Rica used for the management of menopausal symptoms.
Doyle BJ; Frasor J; Bellows LE; Locklear TD; Perez A; Gomez-Laurito J; Mahady GB
Menopause; 2009; 16(4):748-55. PubMed ID: 19424091
[TBL] [Abstract][Full Text] [Related]
11. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line.
Legler J; van den Brink CE; Brouwer A; Murk AJ; van der Saag PT; Vethaak AD; van der Burg B
Toxicol Sci; 1999 Mar; 48(1):55-66. PubMed ID: 10330684
[TBL] [Abstract][Full Text] [Related]
12. Detection of estrogenic potency in wastewater and surface water with three in vitro bioassays.
Murk AJ; Legler J; van Lipzig MM; Meerman JH; Belfroid AC; Spenkelink A; van der Burg B; Rijs GB; Vethaak D
Environ Toxicol Chem; 2002 Jan; 21(1):16-23. PubMed ID: 11808534
[TBL] [Abstract][Full Text] [Related]
13. Estrogen modulates in vitro T cell responses in a concentration- and receptor-dependent manner: effects on intracellular molecular targets and antioxidant enzymes.
Priyanka HP; Krishnan HC; Singh RV; Hima L; Thyagarajan S
Mol Immunol; 2013 Dec; 56(4):328-39. PubMed ID: 23911387
[TBL] [Abstract][Full Text] [Related]
14. MCF-7aro/ERE, a novel cell line for rapid screening of aromatase inhibitors, ERalpha ligands and ERRalpha ligands.
Lui K; Tamura T; Mori T; Zhou D; Chen S
Biochem Pharmacol; 2008 Jul; 76(2):208-15. PubMed ID: 18550029
[TBL] [Abstract][Full Text] [Related]
15. Identification of coregulators influenced by estrogen receptor subtype specific binding of the ER antagonists 4-hydroxytamoxifen and fulvestrant.
Evers NM; Wang S; van den Berg JH; Houtman R; Melchers D; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
Chem Biol Interact; 2014 Sep; 220():222-30. PubMed ID: 25014417
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions.
Takeyoshi M; Yamasaki K; Sawaki M; Nakai M; Noda S; Takatsuki M
Toxicol Lett; 2002 Jan; 126(2):91-8. PubMed ID: 11751013
[TBL] [Abstract][Full Text] [Related]
17. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
18. Cooperative activation of gene expression by agonists and antagonists mediated by estrogen receptor heteroligand dimer complexes.
Liu S; Han SJ; Smith CL
Mol Pharmacol; 2013 May; 83(5):1066-77. PubMed ID: 23462505
[TBL] [Abstract][Full Text] [Related]
19. Estrogen- and antiestrogen-responsiveness of HEC1A endometrial adenocarcinoma cells in culture.
Castro-Rivera E; Safe S
J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):287-95. PubMed ID: 9618030
[TBL] [Abstract][Full Text] [Related]
20. Towards an integrated in vitro strategy for estrogenicity testing.
Wang S; Aarts JM; de Haan LH; Argyriou D; Peijnenburg AA; Rietjens IM; Bovee TF
J Appl Toxicol; 2014 Sep; 34(9):1031-40. PubMed ID: 24114741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
